Showing results (51-60 of 56) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Neuropharmacology|October 20, 2009
AC-260584, an orally bioavailable M(1) muscarinic receptor allosteric agonist, improves cognitive performance in an animal modelStefania Risso Bradley, Jelveh Lameh, Linda Ohrmund, et al.The Journal of Pharmacology and Experimental Therapeutics|September 5, 2008
Identification and characterization of novel small-molecule protease-activated receptor 2 agonistsLuis R Gardell, Jian-Nong Ma, Jimmi Gerner Seitzberg, et al.Journal of Medicinal Chemistry|April 3, 2009
Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonistsHanna Pettersson, Anne Bülow, Fredrik Ek, et al.ACS Chemical Neuroscience|March 25, 2025
Application of Deuterium in an M1 Positive Allosteric Modulator Back-Up Program: The Discovery of VU6045422Julie L Engers, Jinming Li, Changho Han, et al.ACS Chemical Neuroscience|November 26, 2025
Discovery of VU6052254: A Novel, Potent M1 Positive Allosteric ModulatorJulie L Engers, Joseph D Bungard, Christopher C Presley, et al.The Journal of Pharmacology and Experimental Therapeutics|February 14, 2006
Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonistKimberly E Vanover, David M Weiner, Malath Makhay, et al.Pageof 6